1. Single-fraction Radiation Treatment Dose Response in a Genetically Engineered Mouse Model of Medulloblastoma.
- Author
-
Tu, Kevin J., Stewart, Connor E., Williams, Nerissa T., Ma, Yan, Luo, Lixia, Ghosh, Debosir, Weidenhammer, Loren B., Floyd, Scott R., Fan, Yi, Kirsch, David G., Oldham, Mark, and Reitman, Zachary J.
- Subjects
MICE ,LABORATORY mice ,RADIATION doses ,MEDULLOBLASTOMA ,ANIMAL disease models ,TRANSGENIC mice ,RADIOTHERAPY safety - Abstract
Medulloblastoma is the most common malignant brain tumor of children. Although standard of care radiotherapy for pediatric medulloblastoma (PM) can lead to long-term remission or cure in many patients, it can also cause life-long cognitive impairment and other adverse effects. The pathophysiological mechanisms involved in radiation-induced cerebral damage are incompletely understood, and their elucidation may lead to interventions that mitigate radiation toxicity. To explore the mechanisms of radiation-induced cerebral damage, transgenic mouse models of PM and non-tumor-bearing controls were exposed to radiation doses that ranged from 0 to 30 Gy. Between 0–20 Gy, a significant dose-dependent reduction in tumor-associated hydrocephalus and increase in overall survival were observed. However, at 30 Gy, hydrocephalus incidence increased and median overall survival fell to near-untreated levels. Immunohistochemistry revealed that both tumor-bearing and non-tumor-bearing mice treated with 30 Gy of radiation had significantly more reactive astrocytes and microvascular damage compared to untreated controls. This effect was persistent across mice that were given 1 and 2 weeks of recovery time after irradiation. Our data suggest that radiation therapy promotes neural death by inducing long-term neuroinflammation in PM, suggesting radiation delivery methods that limit inflammation may be effective at widening the therapeutic window of radiation therapy in PM patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF